Decoy Therapeutics, Inc. (DCOY)
2.94
-0.03
(-1.01%)
USD |
NASDAQ |
Aug 28, 09:33
Decoy Therapeutics EPS Diluted (TTM) : -47.29 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -47.29 |
| March 31, 2026 | -124.04 |
| December 31, 2025 | -120.88 |
| September 30, 2025 | -286.85 |
| June 30, 2025 | -265.84 |
| March 31, 2025 | -187.00 |
| December 31, 2024 | -189.25 |
| September 30, 2024 | -8.193 |
| June 30, 2024 | -12.64 |
| March 31, 2024 | -21.72 |
| December 31, 2023 | -36.31 |
| September 30, 2023 | -57.13 |
| June 30, 2023 | -103.21 |
| March 31, 2023 | -109.40 |
| December 31, 2022 | -109.68 |
| September 30, 2022 | -103.75 |
| June 30, 2022 | -66.20 |
| December 31, 2021 | -60.70 |
| September 30, 2021 | -59.55 |
| June 30, 2021 | -61.98 |
| March 31, 2021 | -73.82 |
| December 31, 2020 | -105.40 |
| September 30, 2020 | -176.22 |
| June 30, 2020 | -302.86 |
| Date | Value |
|---|---|
| March 31, 2020 | -269953.2 |
| December 31, 2019 | -847196.5 |
| September 30, 2019 | -1.346M |
| June 30, 2019 | -1.527M |
| March 31, 2019 | -1.260M |
| December 31, 2018 | -684774.9 |
| September 30, 2018 | -187844.9 |
| June 30, 2018 | -9806.95 |
| March 31, 2018 | -469879.7 |
| December 31, 2017 | -470031.9 |
| September 30, 2017 | -470131.9 |
| June 30, 2017 | -470681.9 |
| March 31, 2017 | -11650.00 |
| December 31, 2016 | -12250.00 |
| September 30, 2016 | -12400.00 |
| June 30, 2016 | -11800.00 |
| March 31, 2016 | -10600.00 |
| December 31, 2015 | -10500.00 |
| September 30, 2015 | -17050.00 |
| June 30, 2015 | -14665.45 |
| March 31, 2015 | -12315.45 |
| December 31, 2014 | -9365.45 |
| September 30, 2014 | -265.45 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Palatin Technologies, Inc. | -1.367 |
| Unicycive Therapeutics, Inc. | -1.596 |
| Nuvectis Pharma, Inc. | -1.278 |
| ACADIA Pharmaceuticals, Inc. | 2.220 |
| Alnylam Pharmaceuticals, Inc. | 5.923 |